Form 4 for MRNA Moderna
Accepted 2021-09-21 00:00:00 ET · period of report 2021-09-17 · accession 0001127602-21-025659 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-21 | 2021-09-17+ | MRNA | Andres Juan | See remarks | S - Sale+OE | $427.93 | -10.0K | 0 | -100% | -$4.28M |
| DM | 2021-09-21 | 2021-09-17+ | MRNA | Andres Juan | See remarks | M - OptEx | $12.21 | +10.0K | 5,000 | New | +$122.1K |
| DM | 2021-09-21 | 2021-09-17+ | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | -10.0K | 249.8K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-20 | S | D | 5,000 | $417.62 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-20 | M | A | 5,000 | $12.21 | 5,000 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-17 | M | A | 5,000 | $12.21 | 5,000 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-17 | S | D | 5,000 | $438.24 | 0 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-09-17 | M | D | 5,000 | $0.00 | 254,822 | D | $12.21 · — to 2027-08-29 | 5,000 Common Stock | (F2) This option is fully vested and exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-09-20 | M | D | 5,000 | $0.00 | 249,822 | D | $12.21 · — to 2027-08-29 | 5,000 Common Stock | (F2) This option is fully vested and exercisable. |